CS213375B2 - Method of making the new derivatives of imidazole - Google Patents
Method of making the new derivatives of imidazole Download PDFInfo
- Publication number
- CS213375B2 CS213375B2 CS792954A CS295479A CS213375B2 CS 213375 B2 CS213375 B2 CS 213375B2 CS 792954 A CS792954 A CS 792954A CS 295479 A CS295479 A CS 295479A CS 213375 B2 CS213375 B2 CS 213375B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- imidazole
- compound
- preparation
- starting material
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title claims description 5
- 238000004519 manufacturing process Methods 0.000 title description 2
- 239000002253 acid Substances 0.000 claims abstract description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims description 9
- 229910000037 hydrogen sulfide Inorganic materials 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 150000007522 mineralic acids Chemical class 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- CUJKQNHBJRVCET-UHFFFAOYSA-N 1h-imidazol-5-ylmethanethiol Chemical compound SCC1=CNC=N1 CUJKQNHBJRVCET-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 4
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 235000005985 organic acids Nutrition 0.000 claims description 4
- 230000020477 pH reduction Effects 0.000 claims description 4
- 238000010926 purge Methods 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 229910052788 barium Inorganic materials 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 239000007789 gas Substances 0.000 claims description 2
- 229910052712 strontium Inorganic materials 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 229940125715 antihistaminic agent Drugs 0.000 abstract description 2
- 239000000739 antihistaminic agent Substances 0.000 abstract description 2
- 239000000543 intermediate Substances 0.000 abstract description 2
- 229910052976 metal sulfide Inorganic materials 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 150000003573 thiols Chemical class 0.000 abstract 2
- UGHWFYKQWZHCHK-UHFFFAOYSA-N 2-(chloromethyl)-1h-imidazole Chemical compound ClCC1=NC=CN1 UGHWFYKQWZHCHK-UHFFFAOYSA-N 0.000 abstract 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 26
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- -1 thiol derivatives of imidazoles Chemical class 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000002019 disulfides Chemical class 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 150000004763 sulfides Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- HYFUIKONZIAHFT-UHFFFAOYSA-N 5-(bromomethyl)-1h-imidazole Chemical compound BrCC1=CNC=N1 HYFUIKONZIAHFT-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- JGIATAMCQXIDNZ-UHFFFAOYSA-N calcium sulfide Chemical compound [Ca]=S JGIATAMCQXIDNZ-UHFFFAOYSA-N 0.000 description 1
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Tento vynález se- týká - způsobu výroby - nových' ' thlolových derivátů imidazolů. Způsob podle vynálezu - je odvozen od . známé, metody - pro výrobu thiolalkoholů, která - je popsána . - - v - Houben-Weyl „Methoden der organischen - Chemie’’, díl IX, strana 7 až - 11,1955. Tuto metodu nelze přímo použít pro velkou nestálost připravovaných sloučenin- obecného- -yzorce I ,(vzorec uveden níže), protože poskytuje·' -směs sloučenin obecného vzorce I a - jejich disulfídů. - Sloučeniny obecného vzorce I se mohou získat ve vysokém výtěžku - (nad 90 % teorie) - pouze - při- snížení teploty -až na O až 5- - °C. -za- přikapávání roztoku sloučeniny obecného vzorce II (vzorec uveden -níže), a za nepřetržitého profukování reakční směsi - suchým sirovodíkem.The present invention relates to a process for the preparation of novel thiol derivatives of imidazoles. The method of the invention is derived from. known methods - for the production of thioalcohols, which - is described. - - in - Houben-Weyl 'Methoden der organischen - Chemie', Volume IX, pages 7 to - 11,1955. This method is not directly applicable due to the high volatility of the compounds of formula I (formula below), because it provides a mixture of compounds of formula I and their disulfides. The compounds of the formula I can be obtained in high yield - (above 90% of theory) - only by reducing the temperature to 0 to 5 ° C. dropwise addition of a solution of the compound of formula (II) (below), and blowing the reaction mixture continuously with dry hydrogen sulfide.
Způsob -výroby derivátů - imidazolu -obecného vzorce I .......Process for producing imidazole derivatives of the general formula I .......
. R. R
Tí (I) kde- R znamená nižší alkylový zbytek s- nejvýše 4 atomy uhlíku v řetězci, -a jejich solí s anorganickými a organickými kyselinami, podle vynálezu -spočívá v- tom, že- se slouče nina obecného vzorce ' II ···-·'-·-·Those (I) wherein -R represents a lower alkyl radical having at most 4 carbon atoms in the chain, and their salts with inorganic and organic acids, according to the invention, consist in the fact that the compound of formula (II) is: - · - - -
kde R má význam uvedený u vzorce I . -a X znamená atom -halogenu, nechá reagovat s kyselým- - sirníkem· obecného vzorce - -MeHS, kde Me- znamená sodík, - -draslík; - - vápník, arnotúum, - barium nebo - -stroncium. Reakce se provádí -v nižším alkoholu - při teplotě -mezi -0 - až 20 °C za profukování - plynným·- sirovodíkem. Vzniklé - deriváty -imidazolu - ' se - - popřípadě - převedou na - solí - s - anorganickými kyselinami -okyselením - alkoholickým - roztokem příslušných kyselin.wherein R is as defined for Formula I. - and X represents a halogen atom, reacted with an acid sulphide of the formula -MeHS, where Me - represents sodium, - potassium; - - calcium, arnotum, - barium or - strontium. The reaction is carried out in a lower alcohol - at a temperature between -0 - 20 ° C while purging - with hydrogen sulphide gas. The resulting imidazole derivatives are optionally converted into salts with inorganic acids by acidification with an alcoholic solution of the corresponding acids.
Mohou se použít také jiné kyselé sirníky, které - však - v - současné - době nejsou ekonomicky zajímavé,- - což - - ohraničuje- -jejich - - -použitelnost. Protože prakticky všechny ' kyselé sirníky jsou rozpustné -v nlžšfch~aUo>lMleěěhti ve -kterých jsou rozpustné také sloučeniny obecného - vzorce - II, - pracuje - - -se s - -výhodou v absolutním methanolu, ethanolu - nebo- - propanolu. Jiné alkoholy, - jako například iso213373 propylalkohol, amylalkohol nebo allylalkohol · se ' mohou použít také. Výtěžek je‘ však obecně o 10 až 16 '% nižší, než při použití methanolu nebo ethanolu. Jiná rozpouštědla, jako ' například dimethylsulfoxid (DMSO) nejsou vhodná, protože buď mají · -Oddační účinky nebo rozpouštějí značné množství vzdušného kyslíku, což může vést ke vzniku disulfidů.Other acid sulfides may also be used, which - however - at the present time - are not economically interesting, - which - limits - their - applicability. Since virtually all of the acid sulfides are soluble to the extent that the compounds of formula (II) are also soluble, preferably in absolute methanol, ethanol, or propanol. Other alcohols, such as iso213373 propyl alcohol, amyl alcohol or allyl alcohol, may also be used. However, the yield is generally 10 to 16% lower than that of methanol or ethanol. Other solvents, such as dimethylsulfoxide (DMSO), are unsuitable because they either have a respiratory effect or dissolve a significant amount of air oxygen, which can lead to the formation of disulfides.
Sloučeniny obecného vzorce· I jsou v bázickém prostředí nestálé při zvýšené teplotě, protože se velmi· rychle oxidují na disulfidové sloučeniny. Aby sesr zamezilo oxidaci·, reakce se provádí za profukování suchým· sirovodíkem při teplotách mezi 0 a -j-20 °C.The compounds of formula (I) are unstable at elevated temperature in a basic environment because they oxidize very rapidly to disulfide compounds. So you r · prevent oxidation, the reaction is carried out under purging with dry hydrogen sulfide · at temperatures between 0 and J-20 ° C.
Je známo, že kyselé sirníky kovů jsou velmi nestálé a že se· lehce hydrolyzují působením vzdušné vlhkosti a mohou se •oxidovat vzdušným kyslíkem. Proto je výhodné pracovat · . s čerstvě připraveným kyselým sirníkem draselným nebo sodným. Tyto sloučeniny se obecně mohou připravit z alkoxidu draselného nebo sodného v absolutním alkoholu reakcí se suchým sirovodíkem v plynné formě. Sloučeniny obecného· vzorce I ve· formě volných bází jsou velmi nestálé a proto. · ..se? .s... výhodou izolují ve formě solí s anorganickými · nebo organickými kyselinami. Tyto . soli.. ,se , získají, například jednoduše okyselením reakčního prostředí alkoholickým roztokem odpovídajících kyselin. K izolaci se nejlépe osvědčil roztok plynného chlorovodíku v isopropylalkoholu (35% roztok), 96% kyselina sírová v isopropylalkoholu (40% roztok) a ledová kyselina octová v butanolu (50% roztok).Acid metal sulfides are known to be very volatile and to be easily hydrolyzed by exposure to atmospheric moisture and can be oxidized by atmospheric oxygen. Therefore, it is advantageous to work. with freshly prepared potassium or sodium sulphide. These compounds can generally be prepared from potassium or sodium alkoxide in absolute alcohol by reaction with dry hydrogen sulfide in gaseous form. The compounds of formula (I) in the form of the free bases are very volatile and therefore. · ..Se? They are preferably isolated in the form of salts with inorganic or organic acids. These. the salts are obtained, for example, simply by acidifying the reaction medium with an alcoholic solution of the corresponding acids. For isolation, a solution of gaseous hydrogen chloride in isopropyl alcohol (35% solution), 96% sulfuric acid in isopropyl alcohol (40% solution) and glacial acetic acid in butanol (50% solution) proved the best.
• ' Způsobem · podle tohoto vynálezu se vyrobí tyto nové sloučeniny:The process of the present invention produces the following novel compounds:
4(5) -methyl-5 (4) -imidazolm-ethanthlol ve formě hydrochloridu,4 (S) -methyl-5 (4) -imidazole-ethanethanol in the form of the hydrochloride,
4(5) -ethyl-5 (4) -imidazolmethanthiol ve formě sulfátu ai4(5) -butyl-5 (4) -imidazolmethanthiol ve -formě · acetátu.4 (S) -ethyl-5 (4) -imidazole-methanthiol in the form of sulfate and 14 (5) -butyl-5 (4) -imidazole-methanthiol in the form of acetate.
''Sloučeniny obecného· vzorce I slouží jako •n^ez^ii^^ir^i^.kty ,pri syntéze různých antihistaminikj. · která jsou známá jako blokátory Hz-receptoru.The compounds of the formula (I) serve as intermediates in the synthesis of various antihistamines. Which are known as Hz-receptor blockers.
. · Nové · sloučeniny jsou vhodné pro výrobu cimetidinu a jeho derivátů reakcí s novými deriváty· N-kyanoazomethinu, které jsou popsány v československém patentu č. 213 376.. The novel compounds are suitable for the preparation of cimetidine and its derivatives by reaction with the novel N-cyanoazomethine derivatives described in Czechoslovak Patent No. 213,376.
. · · Následující · příklady jsou uvedeny · pro Ilustraci—vynálezu. Tyto příklady · však žádným· .způsobem' vynález neomezují... The following examples are given to illustrate the invention. However, these examples do not limit the invention in any way.
Příklad -I:./. . :Example -I: ./. . :
Hydrachlorld 4(5) -methyl-5 (4) -imidazolmethanthiolu4 (S) -Methyl-5 (4) -imidazole-methanethiol hydrochloride
5,86 g (0,15 mol) drasííku se rozpustí ve 100 ml absolutního methanolu. Tento roztok se potom nasytí sirovodíkem za teploty . 6až 5 °C. Při stejné teplotě se v proudu sirovodíku během 2· hodin přlkape roztok 10,0 · g (0,06· mol) hydrochloridu 4(5)-chlormethylimidazolu v 50 ml absolutního miethanolu. Po přikapání se míchá dalších 30 minut a vyloučená anorganická sůl se potom . odsaje odsávacím filtrem·. Filtrát se okyselí 10 ml 34% roztoku kyseliny -chlorovodíkové v isopropylalkoholu, poté se přidá 0,5. . g . aktivního uhlí a filtruje. Filtrát se odpaří na malý objem a zředí . za tepla 30 až · 40 ml isopropyletheru, načež · začne krystalizace. Získá se 6,8 až 9,5 g produktu (90 až 95 ·%' teorie), který má teplotu tání 226 až 227 °C. IC (KBr): 3100 až 2600, 1630, 820· cm-1.Dissolve 5.86 g (0.15 mol) of dassic acid in 100 ml of absolute methanol. This solution is then saturated with hydrogen sulfide at temperature. 6 to 5 ° C. At the same temperature, a solution of 10.0 g (0.06 mol) of 4 (S) -chloromethylimidazole hydrochloride in 50 ml of absolute methanol was added dropwise in a stream of hydrogen sulfide over 2 hours. After the dropwise addition, it is stirred for a further 30 minutes and the precipitated inorganic salt is then added. suction with suction filter. The filtrate is acidified with 10 ml of a 34% solution of hydrochloric acid in isopropyl alcohol, then 0.5 is added. . g. activated carbon and filtered. The filtrate was evaporated to a small volume and diluted. with 30 to 40 ml of isopropyl ether, followed by crystallization. 6.8 to 9.5 g (90-95% of theory) of melting point 226 DEG-227 DEG C. are obtained. IC (KBr): 3100-2600, 1630, 820 · cm -1.
NMR (DMSO-de) δ v ppm: 2,31 (s,3H), 3,86 (s,2H), 9,00 (s,lH). R£ —0,50, na silikagelové desce eluované dichlormeťhanem, methylalkoholem a kyselinou mravenčí v poměru 8 · : 2 : 0,5 a vyvolané jodovými parami.NMR (DMSO-d 6) δ in ppm: 2.31 (s, 3H), 3.86 (s, 2H), 9.00 (s, 1H). Rf = 0.50, on a silica gel plate, eluted with dichloromethane, methanol and formic acid in a ratio of 8: 2: 0.5 and induced by iodine vapors.
Pro C5H9CIN2S vypočteno: >For C 5 H 9 ClN 2 S calculated:>
36,47 %· C· 5,50 % H· 17,01 % N· 19,47 %7;36.47% · C · 5.50% H · 17.01% N · 19.47% 7;
nalezeno:found:
37,00,1% C, 5,66 · ·% H, 16,48 % · N, 20,02 %S.% H, 16.48;% N, 20.02.
Příklad 2Example 2
Hydrochlorid 4(5) -methyl-5 (4) -imidazol methanťhlolu4 (S) -methyl-5 (4) -imidazole methanol methanol hydrochloride
5,0 g (0,21 mol) sodíku se rozpustí ve 100 mililitrech ethanolu. · Roztok se za chlazení (na teplotu 0 až 5 °C) · nasytí sirovodíkem. K tomuto roztoku se za stálého profukování sirovodíkem běheim · 2 hodin přidá 25,5 g (0,10 mol) · á^j-brom-methyl-S^l-methyl· ímidazolu, rozpuštěného · v · 50 ml absolutního ethanolu. Směs se potom· míchá · dalších 30 minut a anorganická sůl · se odsaje· na odsávacím filtru. Filtrát se ' okyselí 20 ml 34% roztoku kyseliny chlorovodíkové v isopropylalkoholu, · přidá 0,5 g aktivního· uhlí a filtruje.Dissolve 5.0 g (0.21 mol) of sodium in 100 ml of ethanol. The solution is saturated with hydrogen sulfide while cooling (to 0 to 5 ° C). To this solution was added 25.5 g (0.10 mol) of N, N-bromomethyl-S, N-methylimidazole dissolved in 50 ml of absolute ethanol, while purging with hydrogen sulphide for 2 hours. The mixture is then stirred for an additional 30 minutes and the inorganic salt is sucked off on a suction filter. The filtrate was acidified with 20 ml of a 34% solution of hydrochloric acid in isopropanol, added 0.5 g of activated carbon, and filtered.
Filtrát se odpaří zhruba na 40 ml a k teplému roztoku se přidává diisopropylether až do začátku krystalizace. Po ochlazení na 0 °C se provede filtrace a sraženina se promyje směsí methanolu a isopropyletheru v poměru 1: 1. Produkt o teplotě tání 225 až 226 °C (z methanolu) se získá ve výtěžku 93· až 97 · %.The filtrate was evaporated to about 40 ml and diisopropyl ether was added to the warm solution until crystallization began. After cooling to 0 ° C, filtration is performed and the precipitate is washed with a 1: 1 mixture of methanol and isopropyl ether. Melting point 225-226 ° C (from methanol) is obtained in a yield of 93-97%.
IC (KBr): 3100 až 2600, 1630, 820 cm-1. NMR (DMSO-de): δ v ppm: 2,31 (s,3iH), 3,86(s,2H), 9,00 (S,1H).IC (KBr): 3100-2600, 1630, 820 cm -1. NMR (DMSO-d 6): δ in ppm: 2.31 (s, 31H), 3.86 (s, 2H), 9.00 (S, 1H).
NMR (CD30D): · 2,33 (s,3H), 3,85 (s,2H) 8,80 (s,lH).NMR (CD 3 OD): 2.33 (s, 3H), 3.85 (s, 2H), 8.80 (s, 1H).
Pro C5H9CIN2S vypočteno:For C5H9CIN2S calculated:
36,47 % C, 5/50 !% H, 17,01 .% N, 19,47 ·% S;% C, 36.47;% H, 5/50;% N, 17.01;
nalezeno:found:
36,90 % C, 5,96 %· H, 16,68 1% N, 20,00 % S.H, N, 16.68; S, 20.00.
Rf ~ 0,5 s methylenchloridem, methanolem a kyselinou mravenčí v .poměru 8,0 : 2,0 : 0,5.Rf ~ 0.5 with methylene chloride, methanol and formic acid at a ratio of 8.0: 2.0: 0.5.
Příklad 3Example 3
Sulfát 4(5) -ethyl-5 (4 ) -imidazolmethanthiolu4 (S) -ethyl-5 (4) -imidazole methanethiol sulfate
Pracuje se stejným způsobem jako je popsáno· v příkladu 2, avšak rozpustí se 6,5 g kyselého sirníku vápenatého ve 100' ml butanolu a přidá 8,0 g 4(5)-e'thyl-5,(4)brommethylimidaizolu. Okyselení se provede 40% kyselinou sírovou v isopropylalkoholu. Titulní sloučenina se získá ve výtěžku 88 až 90 % ' a má teplotu tání 208 až 210 °C IC (KBr): 3'200 až 2750, 1635, 915, 820 cm-1.The procedure is the same as described in Example 2, but 6.5 g of calcium sulfide is dissolved in 100 ml of butanol and 8.0 g of 4 (5) -ethyl-5, (4) bromomethylimidaisole are added. Acidification is carried out with 40% sulfuric acid in isopropyl alcohol. The title compound is obtained in a yield of 88-90% and has a melting point of 208-210 ° C IC (KBr): 3-200-200, 1635, 915, 820 cm -1.
Pro: C6H12N2O4S2 vypočteno:For: C6H12N2O4S2 calculated:
29,99 % C, 5,04 % H, 11,55 % N1, 26,68 '% S;% C, 29.99;% H, 5.04;% N, 11.55;
nalezeno:found:
29,71 % C, 5,26 % 'H, 11,80 % N, 26,35 ·% S.% H, 5.26;% N, 11.80;% S, 26.35;
Příklad 4Example 4
Acetát 4(5) -butyl-5 (4 ) -imidazolmethanthiolu4 (S) -Butyl-5 (4) -imidazole methanethiol acetate acetate
Pracuje se stejným způsobem jako je popsán v příkladu 2, vychází ' se však ze 6 g 4(5)-butyl-5(4--brommethyiimídazolu a 10 g kyselého sirníku· amonného, ' · přičemž obě sloučeniny jsou rozpuštěné v rsopropyliálkoholu při 4-15 °C. Okyselení se provede 50·% roztokem ledové kyseliny octové v butanolu. Získá se titulní sloučenina o· teplotě tání 126 až 128 °C ve výtěžku 85 až 90 ' %.The procedure is as described in Example 2, but starting with 6 g of 4 (5) -butyl-5- (4-bromomethylimidazole) and 10 g of ammonium sulfide, both of which are dissolved in isopropyl alcohol at 4. The acidification was carried out with a 50% glacial acetic acid in butanol solution to give the title compound, m.p. 126-128 ° C, yield 85-90%.
IC (KBr): 3150 až 2600, 1635, 910, 820 cm-1IC (KBr): 3150-2600, 1635, 910, 820 cm -1
Pro: C10H18N2O2S vypočteno:For: C10H18N2O2S calculated:
52,15 % C, 7,1^^ % H, 12,16 % N, 13,92 % S;% C, 52.15%;% H, 7.14;% N, 12.16;
nalezeno:found:
51,89 % C, 7,99 %' H, 12,01 ·% N 13,65 % S.% H, 12.01;% N, 13.65%.
Claims (6)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH523678 | 1978-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CS213375B2 true CS213375B2 (en) | 1982-04-09 |
Family
ID=4290219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS792954A CS213375B2 (en) | 1978-05-12 | 1979-04-27 | Method of making the new derivatives of imidazole |
Country Status (18)
Country | Link |
---|---|
JP (2) | JPS5440548B1 (en) |
BE (1) | BE875994A (en) |
CS (1) | CS213375B2 (en) |
DE (1) | DE2919147A1 (en) |
DK (1) | DK190379A (en) |
FI (1) | FI791405A7 (en) |
FR (1) | FR2425434A1 (en) |
GB (1) | GB2024206B (en) |
GR (1) | GR68392B (en) |
HU (1) | HU178707B (en) |
IT (1) | IT1166783B (en) |
LU (1) | LU81178A1 (en) |
NL (1) | NL7903731A (en) |
NO (1) | NO791576L (en) |
PL (1) | PL215534A1 (en) |
SE (1) | SE7904060L (en) |
SU (1) | SU784765A3 (en) |
YU (1) | YU110279A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113234018B (en) * | 2021-05-11 | 2022-08-23 | 石家庄市普力制药有限公司 | Production method of cimetidine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5440547A (en) * | 1977-09-07 | 1979-03-30 | Seikosha Kk | Device for adjusting output frequency of frequency divider |
IL56265A (en) * | 1977-12-28 | 1982-08-31 | Om Lab Sa | Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor |
NO784350L (en) * | 1977-12-30 | 1979-07-03 | Crc Ricerca Chim | PROCEDURE FOR ALKYLATION OF 4 (5) -MERCAPTOMETHYL-IMIDAZOLES WITH AZIRIDINE DERIVATIVES |
-
1979
- 1979-04-23 LU LU81178A patent/LU81178A1/en unknown
- 1979-04-27 CS CS792954A patent/CS213375B2/en unknown
- 1979-04-28 GR GR58978A patent/GR68392B/el unknown
- 1979-05-02 BE BE0/194955A patent/BE875994A/en unknown
- 1979-05-02 FI FI791405A patent/FI791405A7/en not_active Application Discontinuation
- 1979-05-08 IT IT22446/79A patent/IT1166783B/en active
- 1979-05-09 DK DK190379A patent/DK190379A/en not_active Application Discontinuation
- 1979-05-09 SE SE7904060A patent/SE7904060L/en not_active Application Discontinuation
- 1979-05-10 SU SU792761900A patent/SU784765A3/en active
- 1979-05-10 YU YU01102/79A patent/YU110279A/en unknown
- 1979-05-10 FR FR7911900A patent/FR2425434A1/en active Pending
- 1979-05-11 HU HU79RI711A patent/HU178707B/en unknown
- 1979-05-11 DE DE19792919147 patent/DE2919147A1/en not_active Ceased
- 1979-05-11 NO NO791576A patent/NO791576L/en unknown
- 1979-05-11 NL NL7903731A patent/NL7903731A/en not_active Application Discontinuation
- 1979-05-12 JP JP5855779A patent/JPS5440548B1/ja active Pending
- 1979-05-12 PL PL21553479A patent/PL215534A1/xx unknown
- 1979-05-14 GB GB7916706A patent/GB2024206B/en not_active Expired
-
1982
- 1982-02-04 JP JP57017396A patent/JPS57150666A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
NL7903731A (en) | 1979-11-14 |
JPS5440548B1 (en) | 1979-12-04 |
JPS57150666A (en) | 1982-09-17 |
YU110279A (en) | 1983-01-21 |
PL215534A1 (en) | 1980-12-01 |
BE875994A (en) | 1979-09-03 |
HU178707B (en) | 1982-06-28 |
IT1166783B (en) | 1987-05-06 |
GB2024206B (en) | 1982-11-10 |
GB2024206A (en) | 1980-01-09 |
FR2425434A1 (en) | 1979-12-07 |
LU81178A1 (en) | 1979-09-10 |
IT7922446A0 (en) | 1979-05-08 |
DE2919147A1 (en) | 1979-11-15 |
DK190379A (en) | 1979-11-13 |
FI791405A7 (en) | 1981-01-01 |
SE7904060L (en) | 1979-11-13 |
NO791576L (en) | 1979-11-13 |
SU784765A3 (en) | 1980-11-30 |
GR68392B (en) | 1981-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080103305A1 (en) | Process for the preparation of imatinib | |
JP4217924B2 (en) | 3-Amino-2-mercaptobenzoic acid derivative and method for producing the same | |
CS213375B2 (en) | Method of making the new derivatives of imidazole | |
WO1998040377A1 (en) | Process for the preparation of 2-[[(2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose | |
US7557218B2 (en) | Hydrates of optionally substituted 2-(2-pyridinyl) methylthio-1H-benzimidazoles and process for the production thereof | |
HU214204B (en) | Process for the preparation of gamma-mercapto-carboxylic acid derivatives | |
US4769456A (en) | Sulfenamide derivatives and their production | |
JPH0245627B2 (en) | ||
KR970002873B1 (en) | 1-methylindazole-3-carboxylic acid process | |
US4900825A (en) | Preparation of 4-nitro-5-imidazolyl ethers and thioethers | |
JPH03145468A (en) | Production of carbostyryl derivative | |
KR950014792B1 (en) | Benzimidazole derivatives and preparation method thereof | |
CS220346B2 (en) | Method of preparing crystalline cimetidine | |
US4147876A (en) | Easily hydrolyzable esters of 4-(2-carboxyethyl)phenyl trans-4-aminomethylcyclohexanecarboxylate and process of use | |
KR970001476B1 (en) | New benzimidazole derivatives with amide groups | |
KR900005955B1 (en) | Benzothiazin dervatives and their preparation | |
KR100471948B1 (en) | 3-amino-2-mercaptobenzoic acid derivatives and preparation method thereof | |
KR960011390B1 (en) | Method for preparing benzimidazole derivatives | |
KR970001477B1 (en) | N-substituted benzimidazole derivatives with amide groups | |
EP0267055B1 (en) | Novel alpha-chloroketone derivative and process for preparation thereof | |
JP2708617B2 (en) | Method for producing 4,4-dialkyl-substituted thiazolidinethione | |
KR910003347B1 (en) | Process for the preparation of piperidil benzamid derivatives | |
KR800001548B1 (en) | Method for preparing 2-hydroxy benzothiazole | |
EP0015631A1 (en) | ((4,5-Dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)thio)acetic acid and its salts | |
KR920003691B1 (en) | Method for preparing benzimidazole derivatives |